Patrick James Orme

Array ( [id] => 5149485 [patent_doc_number] => 20070049545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Antisense modulation of fibroblast growth factor receptor 3 expression' [patent_app_type] => utility [patent_app_number] => 11/505758 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26769 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049545.pdf [firstpage_image] =>[orig_patent_app_number] => 11505758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040217 [patent_doc_number] => 20070092499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Method for changing genetic properties of eukaryotic organism' [patent_app_type] => utility [patent_app_number] => 11/500910 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5398 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092499.pdf [firstpage_image] =>[orig_patent_app_number] => 11500910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142450 [patent_doc_number] => 20070004666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Methods for modulating apoptotic cell death' [patent_app_type] => utility [patent_app_number] => 11/501319 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14492 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004666.pdf [firstpage_image] =>[orig_patent_app_number] => 11501319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404619 [patent_doc_number] => 20090239933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'HEPATITIS C ANTIVIRALS' [patent_app_type] => utility [patent_app_number] => 11/997548 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16768 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239933.pdf [firstpage_image] =>[orig_patent_app_number] => 11997548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5235960 [patent_doc_number] => 20070128116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'MULTIFUNCTIONAL CORE FOR MOLECULAR IMAGING AND TARGETED DELIVERY OF MACROMOLECULES AND DRUGS' [patent_app_type] => utility [patent_app_number] => 11/460500 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16986 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128116.pdf [firstpage_image] =>[orig_patent_app_number] => 11460500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041158 [patent_doc_number] => 20070093440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Medical treatment' [patent_app_type] => utility [patent_app_number] => 11/495015 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 79550 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093440.pdf [firstpage_image] =>[orig_patent_app_number] => 11495015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53235 [patent_doc_number] => 07772200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'iRNA agents targeted to the Rho-A gene' [patent_app_type] => utility [patent_app_number] => 11/491367 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24503 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772200.pdf [firstpage_image] =>[orig_patent_app_number] => 11491367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056817 [patent_doc_number] => 20070059739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Pure miRNA Sample Preparation Method' [patent_app_type] => utility [patent_app_number] => 11/458077 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10534 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059739.pdf [firstpage_image] =>[orig_patent_app_number] => 11458077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149484 [patent_doc_number] => 20070049544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Antisense IAP nucleobase oligomers and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/477452 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21849 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049544.pdf [firstpage_image] =>[orig_patent_app_number] => 11477452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 197126 [patent_doc_number] => 07638620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Antisense IAP nucleobase oligomers and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/448862 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 47 [patent_no_of_words] => 21882 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638620.pdf [firstpage_image] =>[orig_patent_app_number] => 11448862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859829 [patent_doc_number] => 20060229273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'High affinity oligonucleotide ligands to growth factors' [patent_app_type] => utility [patent_app_number] => 11/444181 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 32989 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229273.pdf [firstpage_image] =>[orig_patent_app_number] => 11444181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051900 [patent_doc_number] => 20070032445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Antisense IAP nucleobase oligomers and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/442380 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21822 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032445.pdf [firstpage_image] =>[orig_patent_app_number] => 11442380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971220 [patent_doc_number] => 20070111222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Nucleic acid aptamer-based compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/438758 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 24473 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111222.pdf [firstpage_image] =>[orig_patent_app_number] => 11438758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 333786 [patent_doc_number] => 07507196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Antisense antiviral compounds and methods for treating a filovirus infection' [patent_app_type] => utility [patent_app_number] => 11/433840 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 44 [patent_no_of_words] => 17845 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507196.pdf [firstpage_image] =>[orig_patent_app_number] => 11433840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555668 [patent_doc_number] => 08067569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Splice-region antisense composition and method' [patent_app_type] => utility [patent_app_number] => 11/433214 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 12 [patent_no_of_words] => 14570 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067569.pdf [firstpage_image] =>[orig_patent_app_number] => 11433214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685250 [patent_doc_number] => 20100120891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'USE OF A GALECTIN-1-TARGETED RNAI-BASED APPROACH FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/911342 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15462 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120891.pdf [firstpage_image] =>[orig_patent_app_number] => 11911342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239606 [patent_doc_number] => 07592323 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-22 [patent_title] => 'TRPM-2 antisense therapy' [patent_app_type] => utility [patent_app_number] => 11/276581 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 4830 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592323.pdf [firstpage_image] =>[orig_patent_app_number] => 11276581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672979 [patent_doc_number] => 20060178334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Double-stranded and single-stranded RNA molecules with 5 \' triphosphates and their use for inducing interferon' [patent_app_type] => utility [patent_app_number] => 11/347833 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 15049 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178334.pdf [firstpage_image] =>[orig_patent_app_number] => 11347833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13484 [patent_doc_number] => 07803611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'RNAi expression constructs' [patent_app_type] => utility [patent_app_number] => 11/347028 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 12299 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803611.pdf [firstpage_image] =>[orig_patent_app_number] => 11347028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7988351 [patent_doc_number] => 08076471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'RNAi expression constructs' [patent_app_type] => utility [patent_app_number] => 11/883645 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 12322 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076471.pdf [firstpage_image] =>[orig_patent_app_number] => 11883645 [rel_patent_id] =>[rel_patent_doc_number] =>)